ROXO 150

País: Israel

Língua: inglês

Origem: Ministry of Health

Ingredientes ativos:

ROXITHROMYCIN

Disponível em:

UNIPHARM LTD, ISRAEL

Código ATC:

J01FA06

Forma farmacêutica:

TABLETS

Composição:

ROXITHROMYCIN 150 MG

Via de administração:

PER OS

Tipo de prescrição:

Required

Fabricado por:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Grupo terapêutico:

ROXITHROMYCIN

Área terapêutica:

ROXITHROMYCIN

Indicações terapêuticas:

For the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ENT bronchopulmonary, genital and skin manifestations.

Data de autorização:

2011-08-31

Folheto informativo - Bula

PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s
prescription only.
ROXO 150
Tablets
ACTIVE INGREDIENT:
Each tablet contains:
Roxithromycin 150 mg
Inactive ingredients )see section 6).
Read this leaflet carefully in its entirety
before using the medicine. Keep this leaflet;
you may need to read it again.
This leaflet contains concise information about
the medicine. If you have further questions,
refer to the doctor or pharmacist.
This medicine has been prescribed for you.
Do not pass it on to others. It may harm
them even if it seems to you that their
medical condition is similar.
If a side effect worsens or if a side effect not
mentioned in this leaflet occurs, please refer
to a doctor or pharmacist.
1. WHAT IS THE MEDICINE INTENDED
FOR?
The medicine is intended for the treatment
of infections caused by bacteria susceptible
to roxithromycin, such as infections of the
respiratory tract, including nose, ear and
throat, infections of the skin and genitals.
THERAPEUTIC GROUP: Macrolide antibiotic.
2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE:
∙ if there is a known sensitivity to
roxithromycin or to any of the other
ingredients of the medicine, or to another
medicine of the macrolide group )e.g.,
erythromycin).
∙ if you are being concomitantly treated
with ergot derivatives for treatment
of migraine )such as ergotamine and
dihydroergotamine).
∙ if you are being concomitantly treated
with colchicine )to treat gout).
∙ if you are being concomitantly treated
with
medicines
that
can
cause
arrhythmias, such as: cisapride )for
treatment of esophageal reflux), pimozide
)a neuroleptic
medicine
) or medicines
for treatment of allergies containing
terfenadine or astemizole.
∙ when you are breastfeeding and your
baby is being treated with the medicine
cisapride.
SPECIAL WARNINGS REGARDING USE OF THE
MEDICINE: BEFORE TREATMENT WITH ROXO 150, TELL THE
DOCTOR IF:
- you have an intolerance to certain
sugars.
- you are pregna